Shannon James Samuel

MannKind Corporation · Director

Shannon James Samuel is listed in filings as Director at MannKind Corporation. This profile follows SEC Form 4 activity through May 22, 2026, including purchase activity. Recent filings connect the profile to MannKind Corporation (MNKD) and Xilio Therapeutics, Inc. (XLO). The current snapshot covers public activity from Jun 17, 2024 to May 22, 2026. Reported amounts are shown as $44.0K to $17.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Xilio Therapeutics, Inc.XLO$17k25k sharesBuyJun 17, 2025$0.6886$8.52
Xilio Therapeutics, Inc.XLO$31k45k sharesBuyJun 16, 2025$0.686$8.52